Clinical trials

  • BEVACIZUMAB for Metastatic colorectal cancer (unresectable)
  • losartan potassium for Glioblastoma|Brain metastases from non-small-cell lung cancer
  • CD19-targeted CAR T cells for Myasthenia gravis | Progressive multiple sclerosis | Relapsing multiple sclerosis
  • ABBV-CLS-484 for Metastatic or locally advanced tumours | Advanced cancer
  • SATRALIZUMAB for Neuromyelitis optica spectrum disorder (AQP4 antibody-positive)
  • FINGOLIMOD for Multiple sclerosis
  • PRALATREXATE for Peripheral T-cell lymphoma
  • DISITAMAB VEDOTIN for Breast cancer (HER2-positive and HER2-low) | Gastric cancer | Gastroesophageal junction adenocarcinoma | Oesophageal adenocarcinoma
  • OSIMERTINIB for Non-small cell lung cancer (unresectable, stage III)
  • NMD670 for Myasthenia gravis (AChR/MuSK antibody positive)
  • DASATINIB for Cytokine release syndrome | Relapsed/refractory multiple myeloma
  • PERAMPANEL for Childhood epilepsy | Epilepsy